BoniSnow Capsules
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80090778
- Status
- Active licence
- Licence date
- 20 February 2019
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 200 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Collagène hydrolysé Source : Poissons -Peau | 100 milligramme | Not calculated |
| L-Glutathione Source : Glutathione | 125 milligramme | Not calculated |
| L-arginine Source : L-arginine | 25 milligramme | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 25 milligramme | Not calculated |
| Aloe vera Source : Gel de la feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 150 milligramme | 7.5 milligramme | Not calculated |
| Vitamine C Source : Ascorbate de calcium | 50 milligramme | 200,000 µg |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 12.5 milligramme | Not calculated |
| Lactobacillus casei Source : LC-11 | 2.5 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Cellule entière | 2.5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Silice pyrogénée, Gélatine, Stéarate de magnésium, Fécule de pomme de terre, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 days |
Uses authorised in Canada
Provides antioxidants for the maintenance of good health. Source of (an) amino acid(s) involved in muscle protein synthesis. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of an antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps the body to metabolize fats and proteins. Helps in wound healing. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause mild gastrointestinal disturbance.
- Contre-indications
If you are taking antibiotics, do not use this product. If you are taking nitroglycerin, do not use this product. If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms worsen, consult a health care practitioner. If you have kidney stones, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar). If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80090778
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.